Not logged inThe Progress Test of the European Hematology Association: A New Tool for Continuous Learning
Wondergem, Marielle J.; Almeida, Antonio; Brolin, Janaki; Fernandez de Larrea, Carlos; van Havre, Nathalie; Hemker, Bas T.; Hollegien, Wietske; Navarro, Jose-Tomas; Prahladan, Mahesh; Rovo, Alicia; Birgegard, Gunnar .png)
Share.png)
SaveShare Save Share Save Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetBarbuil, Tiziano; Tefferi, Ayalew; Vannucchi, Alessandro M.; Passamonti, Francesco; Silvers, Richard T.; Hoffman, Ronald; Verstovsek, Srdan; Mesa, Ruben; Kiladjian, Jean-Jacques; Hehlmann, Rudiger; Reiter, Andreas; Cervantes, Francisco; Harrison, Claire; Mc Mullin, Mary Frances; Hasselbalch, Hans Carl; Koschmieder, Steffen; Marchetti, Monia; Bacigalupo, Andrea; Finazzil, Guido; Kroeger, Nicolaus; Griesshammer, Martin; Birgegard, Gunnar; Barosi, Giovanni Share Save Share Save Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendationsMarchetti, M.; Barosi, G.; Cervantes, F.; Birgegard, G.; Griesshammer, M.; Harrison, C.; Hehlmann, R.; Kiladjian, J-J; Kroeger, N.; McMullin, M. F.; Passamonti, F.; Vannucchi, A.; Barbui, T. Share Save Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupGeyer, Holly L.; Kosiorek, Heidi; Dueck, Amylou C.; Scherber, Robyn; Slot, Stefanie; Zweegman, Sonja; te Boekhorst, Peter A. W.; Senyak, Zhenya; Schouten, Harry C.; Sackmann, Federico; Kerguelen Fuentes, Ana; Hernandez-Maraver, Dolores; Pahl, Heike L.; Griesshammer, Martin; Stegelmann, Frank; Doehner, Konstanze; Lehmann, Thomas; Bonatz, Karin; Reiter, Andreas; Boyer, Francoise; Etienne, Gabriel; Ianotto, Jean-Christophe; Ranta, Dana; Roy, Lydia; Cahn, Jean-Yves; Harrison, Claire N.; Radia, Deepti; Muxi, Pablo; Maldonado, Norman; Besses, Carlos; Cervantes, Francisco; Johansson, Peter L.; Barbui, Tiziano; Barosi, Giovanni; Vannucchi, Alessandro M.; Paoli, Chiara; Passamonti, Francesco; Andreasson, Bjorn; Ferrari, Maria L.; Rambaldi, Alessandro; Samuelsson, Jan; Cannon, Keith; Birgegard, Gunnar; Xiao, Zhijian; Xu, Zefeng; Zhang, Yue; Sun, Xiujuan; Xu, Junqing; Kiladjian, Jean-Jacques; Zhang, Peihong; Gale, Robert Peter; Mesa, Ruben A. Share Save The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study GroupGeyer, Holly L.; Andreasson, Bjorn; Kosiorek, Heidi E.; Dueck, Amylou C.; Scherber, Robyn M.; Martin, Kari A.; Butler, Kristina A.; Harrison, Claire N.; Radia, Deepti H.; Cervantes, Francisco; Kiladjian, Jean-Jacques; Reiter, Andreas; Birgegard, Gunnar; Passamonti, Francesco; Senyak, Zhenya; Vannucchi, Alessandro M.; Paoli, Chiara; Xiao, Zhijian; Samuelsson, Jan; Mesa, Ruben A. Share Save European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel DiseasesDignass, Axel U.; Gasche, Christoph; Bettenworth, Dominik; Birgegard, Gunnar; Danese, Silvio; Gisbert, Javier P.; Gomollon, Fernando; Iqbal, Tariq; Katsanos, Konstantinos; Koutroubakis, Ioannis; Magro, Fernando; Savoye, Guillaume; Stein, Juergen; Vavricka, Stephan Share Save Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)Barosi, G.; Tefferi, A.; Besses, C.; Birgegard, G.; Cervantes, F.; Finazzi, G.; Gisslinger, H.; Griesshammer, M.; Harrison, C.; Hehlmann, R.; Hermouet, S.; Kiladjian, J-J; Kroeger, N.; Mesa, R.; Mc Mullin, M. F.; Pardanani, A.; Passamonti, F.; Samuelsson, J.; Vannucchi, A. M.; Reiter, A.; Silver, R. T.; Verstovsek, S.; Tognoni, G.; Barbui, T. Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group (vol 21, pg 277, 2007)Barosi, G.; Besses, C.; Birgegard, G.; Briere, J.; Cervantes, F.; Finazzi, G.; Gisslinger, H.; Griesshammer, M.; Gugliotta, L.; Harrison, C.; Hasselbalch, H.; Lengfelder, E.; Reilly, J. T.; Michiels, J. J.; Barbui, T. Share Save A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupBarosi, G.; Besses, C.; Birgegard, G.; Briere, J.; Cervantes, F.; Finazzi, G.; Gisslinger, H.; Griesshammer, M.; Gugliotta, L.; Harrison, C.; Hasselbalch, H.; Lengfelder, E.; Reilly, J. T.; Michiels, J. J.; Barbui, T. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
